T. Okabayashi et al., FREE-THYROXINE CONCENTRATIONS IN SERUM MEASURED BY EQUILIBRIUM DIALYSIS IN CHRONIC-RENAL-FAILURE, Clinical chemistry, 42(10), 1996, pp. 1616-1620
The serum concentration of free thyroxine (FT4) is often low in patien
ts with chronic renal failure (CRF) with low serum concentrations of t
riiodothyronine (T-3). We evaluated the serum FT4 concentration by usi
ng both an equilibrium dialysis RIA kit (D-FT4) and a labeled-antibody
kit (M-FT4) in two different groups of CRF patients, undergoing chron
ic hemodialysis (HD, n = 145) or not (non-HD, n = 30), and in a group
of normal healthy subjects (n = 58). Thyroid peroxidase antibodies and
thyroglobulin antibodies were not detected in any patient. Serum FT4
concentrations (mean +/- SD, pmol/L) by the D- and M-FT4 assays were,
respectively, 21.5 +/- 4.6 and 16.6 +/- 2.0 in the healthy subjects, 1
7.8 +/- 4.3 and 13.9 +/- 3.6 in the non-HD patients, and 16.9 +/- 4.9
and 10.7 +/- 1.9 in the HD patients. By the D-FT4 assay, results for b
oth CRF groups n ere significantly different from those for the health
y group (P < 0.01), as were the results for each pair of groups by the
M-FT4 assay (P < 0.01). FT4 values were reported as being within the
healthy reference range by D-FT4 in 73 of 113 HD subjects who had low
T-3 and low M-FT4 values. Serum FT4 concentrations measured by both as
say kits showed a significant inverse correlation with the serum conce
ntration of creatinine (P < 0.01), but the serum concentrations of sex
-hormone-binding globulin did not differ significantly among the three
groups, Our results indicate that the low FT4 concentration measured
by D-FT4 in patients with CRF, particularly those on HD, probably refl
ects the actual, mild nonthyroidal illness of renal failure.